STOCK TITAN

TransMedics Group, Inc. SEC Filings

TMDX NASDAQ

Welcome to our dedicated page for TransMedics Group SEC filings (Ticker: TMDX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TransMedics Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TransMedics Group's regulatory disclosures and financial reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.46%
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.46%
Tags
current report

FAQ

How many TransMedics Group (TMDX) SEC filings are available on StockTitan?

StockTitan tracks 52 SEC filings for TransMedics Group (TMDX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for TransMedics Group (TMDX)?

The most recent SEC filing for TransMedics Group (TMDX) was filed on July 30, 2025.